Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™
Go back to Natera and Angiex Partner to Assess Response to Investigational Nuclear-Delivered Antibody-Drug Conjugate™ Using Signatera™| (NASDAQ: NTRA) | Delayed: 369.39 +3.08 (0.84%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $366.31 | 52 Week High | $13.80 | |||
| Open | $365.78 | 52 Week Low | $6.52 | |||
| Day High | $369.69 | P/E | N/A | |||
| Day Low | $358.90 | EPS | $0.00 | |||
| Volume | 3,718,171 | |||||

